Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2014 Sep;20(8):836-47. doi: 10.1017/S135561771400068X. Epub 2014 Aug 26.

PMID:
25156329
[PubMed - in process]
Free PMC Article
2.

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Paterson RW, Bartlett JW, Blennow K, Fox NC; Alzheimer's Disease Neuroimaging Initiative, Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM.

Transl Psychiatry. 2014 Jul 29;4:e419. doi: 10.1038/tp.2014.58.

PMID:
25072324
[PubMed - in process]
Free PMC Article
3.

History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.

Durazzo TC, Mattsson N, Weiner MW, Korecka M, Trojanowski JQ, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Drug Alcohol Depend. 2014 Sep 1;142:262-8. doi: 10.1016/j.drugalcdep.2014.06.030. Epub 2014 Jul 3.

PMID:
25037769
[PubMed - in process]
4.

Altered effective connectivity patterns of the default mode network in Alzheimer's disease: an fMRI study.

Zhong Y, Huang L, Cai S, Zhang Y, von Deneen KM, Ren A, Ren J; Alzheimer's Disease Neuroimaging Initiative.

Neurosci Lett. 2014 Aug 22;578:171-5. doi: 10.1016/j.neulet.2014.06.043. Epub 2014 Jul 1.

PMID:
24996191
[PubMed - in process]
5.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR Jr, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH; AL-108-231 Investigators.

Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27.

PMID:
24873720
[PubMed - indexed for MEDLINE]
6.

Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease.

Szigeti K, Kellermayer B, Lentini JM, Trummer B, Lal D, Doody RS, Yan L, Liu S, Ma C; Texas Alzheimer Research and Care Consortium.

J Alzheimers Dis. 2014;41(4):1063-71. doi: 10.3233/JAD-132693.

PMID:
24787912
[PubMed - in process]
7.

Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.

Pérez-Palma E, Bustos BI, Villamán CF, Alarcón MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV; Alzheimer's Disease Neuroimaging Initiative; NIA-LOAD/NCRAD Family Study Group.

PLoS One. 2014 Apr 22;9(4):e95413. doi: 10.1371/journal.pone.0095413. eCollection 2014.

PMID:
24755620
[PubMed - in process]
Free PMC Article
8.

Automatic ROI selection in structural brain MRI using SOM 3D projection.

Ortiz A, Górriz JM, Ramírez J, Martinez-Murcia FJ; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2014 Apr 11;9(4):e93851. doi: 10.1371/journal.pone.0093851. eCollection 2014.

PMID:
24728041
[PubMed - in process]
Free PMC Article
9.

Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

Doody RS, Farlow M, Aisen PS; Alzheimer’s Disease Cooperative Study Data Analysis and Publication Committee.

N Engl J Med. 2014 Apr 10;370(15):1460. doi: 10.1056/NEJMc1402193. No abstract available.

PMID:
24716687
[PubMed - indexed for MEDLINE]
Free Article
10.

Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data.

Zhang Y, Xu Z, Shen X, Pan W; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 Aug 1;96:309-25. doi: 10.1016/j.neuroimage.2014.03.061. Epub 2014 Apr 1.

PMID:
24704269
[PubMed - in process]
11.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2014 May;137(Pt 5):1550-61. doi: 10.1093/brain/awu043. Epub 2014 Mar 12.

PMID:
24625697
[PubMed - indexed for MEDLINE]
12.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

PMID:
24450891
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R; Alzheimer's Disease Cooperative Study Steering Committee; Solanezumab Study Group.

N Engl J Med. 2014 Jan 23;370(4):311-21. doi: 10.1056/NEJMoa1312889.

PMID:
24450890
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.

Mattsson N, Insel P, Tosun D, Zhang J, Jack CR Jr, Galasko D, Weiner M; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013 Dec 31;8(12):e85443. doi: 10.1371/journal.pone.0085443. eCollection 2013.

PMID:
24392009
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Semagacestat for treatment of Alzheimer's disease.

Doody RS, Aisen PS, Iwatsubo T.

N Engl J Med. 2013 Oct 24;369(17):1661. doi: 10.1056/NEJMc1310845. No abstract available.

PMID:
24152267
[PubMed - indexed for MEDLINE]
Free Article
16.

Molecular neuropsychology: creation of test-specific blood biomarker algorithms.

O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P, Wilhelmsen K, Doody R, Diaz-Arrastia R; Texas Alzheimer’s Research and Care Consortium.

Dement Geriatr Cogn Disord. 2014;37(1-2):45-57. doi: 10.1159/000345605. Epub 2013 Jan 3.

PMID:
24107792
[PubMed - indexed for MEDLINE]
17.

Does ethnicity moderate dementia's biomarkers?

Royall DR, Palmer RF; Texas Alzheimer's Research and Care Consortium.

Neurobiol Aging. 2014 Feb;35(2):336-44. doi: 10.1016/j.neurobiolaging.2013.08.006. Epub 2013 Sep 18.

PMID:
24054829
[PubMed - indexed for MEDLINE]
18.

Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.

Bryant C, Giovanello KS, Ibrahim JG, Chang J, Shen D, Peterson BS, Zhu H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013 Aug 28;8(8):e71723. doi: 10.1371/journal.pone.0071723. eCollection 2013.

PMID:
24015190
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS; Alzheimer's Disease Cooperative Study Steering Committee, Siemers E, Sethuraman G, Mohs R; Semagacestat Study Group.

N Engl J Med. 2013 Jul 25;369(4):341-50. doi: 10.1056/NEJMoa1210951.

PMID:
23883379
[PubMed - indexed for MEDLINE]
Free Article
20.

Deformable templates guided discriminative models for robust 3D brain MRI segmentation.

Liu CY, Iglesias JE, Tu Z; Alzheimer's Disease Neuroimaging Initiative.

Neuroinformatics. 2013 Oct;11(4):447-68. doi: 10.1007/s12021-013-9190-5.

PMID:
23836390
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk